F.
Non vérifié

F. Hoffmann-La Roche Ltd

Ce que nous écrivons

Annonces ÉconomiquesIndustrie pharmaceutiquePublicité/Marketing/Médias/Communication
13/11/2026
Industrie pharmaceutique
Annonces Économiques
CHMP recommends EU approval of Roche’s Gazyva/Gazyvaro for systemic lupus erythematosus (SLE)
1.00
27/10/2026
Industrie pharmaceutique
Annonces Économiques
Publicité/Marketing/Médias/Communication
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
1.00
25/10/2026
Industrie pharmaceutique
Annonces Économiques
Publicité/Marketing/Médias/Communication
Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer
1.00
21/10/2026
Industrie pharmaceutique
Annonces Économiques
Publicité/Marketing/Médias/Communication
Roche presents new pivotal trial data across broad neuroimmunology portfolio at MSToronto2026
1.00
18/10/2026
Industrie pharmaceutique
Annonces Économiques
Publicité/Marketing/Médias/Communication
Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0